MedGenome raises USD 47.5 mn in Series E funding led by Maj Invest and Novo Holdings to expand genomics access across India and emerging markets.

Jul 21, 2025•12 days ago

Amount Raised

$47.5 Million

Round Type

SERIES E

BengaluruBiotechnologyHealth Care

Investors

SofinaNovo HoldingsMaj Invest

Description

MedGenome has raised USD 47.5 million in a Series E funding round from Maj Invest and existing investor Novo Holdings. The round also included participation from Sofina. This funding will help broaden access to its genomics and integrated diagnostics solutions. It reflects the growing adoption of genomics in personalized healthcare in India and other emerging economies.

Company Information

Company

MedGenome

Location

Bengaluru, Karnataka, India

About

MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends